Form 4: InMed Pharmaceuticals Insider Buys Shares
Insider Transaction (Form 4)
ADAR1 Capital Management, LLC and 1 other reported changes in beneficial ownership of InMed Pharmaceuticals Inc. common stock on October 13, 2026.
Summary
- Open-market purchase: acquired 564 Common Shares at $1.33 ($750) on October 13, 2026; holds 946,488 after (Indirect).
- Open-market purchase: acquired 8,021 Common Shares at $1.33 ($10,668) on October 14, 2026; holds 954,509 after (Indirect).
- Open-market purchase: acquired 984 Common Shares at $1.32 ($1,301) on October 15, 2026; holds 955,493 after (Indirect).
Sentiment
Score: 7
Explanation: StockSavvy.ai views this as a bullish signal: an insider made an open-market purchase of $12,719, committing personal capital to the stock.
Insider Transactions
ADAR1 Capital Management, LLC — 10% owner
Daniel Schneeberger — 10% owner
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-10-13 | Open-market purchase | Common Shares | 564 | $1 | $750 | 946,488 |
| 2026-10-14 | Open-market purchase | Common Shares | 8,021 | $1 | $10.7K | 954,509 |
| 2026-10-15 | Open-market purchase | Common Shares | 984 | $1 | $1.3K | 955,493 |
Key Dates
| Date | Description |
|---|---|
| 2026-10-13 | Open-market purchase (564 shares) |
| 2026-10-14 | Open-market purchase (8,021 shares) |
| 2026-10-15 | Open-market purchase (984 shares) |
Keywords
insider transaction, Form 4, INM, InMed Pharmaceuticals Inc., bullish, ADAR1 Capital Management, LLC, Daniel Schneeberger
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.